The FDA is undergoing a significant workforce reduction, losing nearly 20% of its staff due to recent layoffs and continued departures. Agency employees report low morale fueled by political interference, administrative cutbacks, and distrust in leadership, which threatens the FDA’s operational capacity across drug, device, biologics, and food regulatory functions. The staffing crisis coincides with increased demands amid evolving regulatory challenges, raising concerns over future regulatory oversight efficacy.